Abstract
Telomerase is a telomere-specific DNA polymerase consisting of protein and RNA components, which is activated in germline cells and the majority of cancers and serves to counter the consequences of telomere shortening. The protein component, hTERT, is believed to be the catalytic subunit of human telomerase and its expression at the mRNA level correlates well with telomerase activity in vitro. Current techniques for assaying telomerase activity detect only the mean activity in a sample and are unable to isolate specific cell sub-populations. This report describes the development and validation of a cellular, immunofluorescence-based flow cytometry assay that allows detection of intranuclear hTERT while maintaining identifiable cell population characteristics. The assay was shown to be both sensitive to changes in telomerase expression and was semi-quantitative. In both cell line differentiation experiments and in primary cells, a good correlation existed between hTERT expression measured by flow cytometry and telomerase activity detected by the telomeric repeat amplification protocol (TRAP). The method developed offers a quick, simple and reproducible cellular-based assay for hTERT expression. This assay will provide a useful, new tool for future investigations, facilitating the analysis of hTERT expression in mixed cell populations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Moyzis RK, Buckingham J, Cram L, Dani M, Deaven L, Jones M, Meyne J, Ratliff R, Wu J . A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes Proc Natl Acad Sci USA 1988 85: 6622–6626
Blackburn EH . Structure and function of telomeres Nature 1991 350: 569–573
Watson JD . Origin of concatemeric T7 DNA Nat New Biol 1972 239: 197–201
Levy MZ, Allsopp R, Futcher A, Greider C, Harley C . Telomere end replication problem and cell aging J Mol Biol 1992 225: 951–960
Greider CW, Blackburn EH . Identification of a specific telomere terminal transferase activity in Tetrahymena extracts Cell 1985 43: 405–413
Greider CW, Blackburn EH . The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity Cell 1987 51: 887–898
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . Specific association of human telomerase activity with immortal cells and cancer Science 1994 266: 2011–2015
Harley CB . Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991 256: 271–282
Broccoli D, Young JW, de Lange T . Telomerase activity in normal and malignant hematopoietic cells Proc Natl Acad Sci USA 1995 92: 9082–9086
Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, Weinberg RA . Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase Oncogene 1998 16: 1217–1222
Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S . Telomerase activity in normal leukocytes and in hematologic malignancies Blood 1995 85: 2315–2320
Bechter OE, Eisterer W, Pall G, Hilbe W, Kuhr T, Thaler J . Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia Cancer Res 1998 58: 4918–4922
Greaves M . Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 1996 12: 127–128
Engelhardt M, Kumar R, Albanell J, Pettengell R, Han, W ., Moore MA. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells Blood 1997 90: 182–193
Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC . Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds Proc Natl Acad Sci USA 1978 75: 2458–2462
Xu D, Gruber A, Peterson C, Pisa P . Suppression of telomerase activity in HL60 cells after treatment with differentiating agents Leukemia 1996 10: 1354–1357
Yamada O, Takanashi M, Ujihara M, Mizoguchi H . Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change Leuk Res 1998 22: 711–717
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA . hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 1997 90: 785–795
Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R . Expression profile of the putative catalytic subunit of the telomerase gene Cancer Res 1998 58: 622–625
Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek M, Shay J, Ishioka S, Yamakido M . Activation of telomerase in human lymphocytes and hematopoietic progenitor cells J Immunol 1995 155: 3711–3715
Robertson JD, Gale RE, Wynn RF, Dougal M, Linch DC, Testa NG, Chopra R . Dynamics of telomere shortening in neutrophils and T-lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns Br J Haematol 2000 109: 272–279
Peng B, Zhang M, Sun R, Lin YC, Chong SY, Lai H, Stein D, Raveche ES . The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL) Leuk Res 1998 22: 509–516
Acknowledgements
ASM Ali is supported by the University of Manchester and the JHG Holt Scholarship and Special Exhibition in Medicine. R Chopra is supported by the Christie Hospital Leukaemia Endowment fund and Chugai Pharmaceuticals. J Robertson is supported by the Leukaemia Research Fund. NG Testa is supported by the Cancer Research Campaign.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ali, A., Chopra, R., Robertson, J. et al. Detection of hTERT protein by flow cytometry. Leukemia 14, 2176–2181 (2000). https://doi.org/10.1038/sj.leu.2401950
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401950
Keywords
This article is cited by
-
Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis
International Journal of Clinical Oncology (2011)